AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PORVAIR PLC

Regulatory Filings Dec 10, 2024

5280_rns_2024-12-10_da716870-89d8-43b4-b564-5b38078adb12.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4137P

Porvair PLC

10 December 2024

FOR IMMEDIATE RELEASE                                                                                 10 December 2024

porvair logo

Porvair plc

("Porvair", the "Group" or the "Company")

Trading update for the year ended 30 November 2024 and notice of results

Pre-close trading update

The Group expects revenue growth to be around 9% (13% at constant currency), with adjusted earnings per share marginally ahead of market expectations.  Net cash at 30 November 2024 was approximately £14 million.

As previously announced, Hooman Caman Javvi will join the Group on 6 January 2025 as Chief Executive Officer designate and Director of the Company.  He will succeed Ben Stocks following his retirement at the Company's AGM on 15 April 2025.

Notice of results

Porvair will announce its results for the year ended 30 November 2024 on Monday 10 February 2025 .

For further information please contact:

Porvair plc +44(0)1553 765 500
Ben Stocks, Group Chief Executive

James Mills, Group Finance Director
Burson Buchanan +44(0)20 7466 5000
Charles Ryland / Stephanie Whitmore / Jack Devoy

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses.  Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets.  It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFZMGZMLKGDZZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.